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investigates 6 domains: anxiety/depressed mood, well-be-
ing, somatic symptoms, memory/concentration, vasomo-
tor symptoms, and sleep problem. Two optional modules
evaluate sexual behavior and menstrual symptoms. A
score is calculated for each domain and each optional
module. Scores have been calculated using this new scor-
ing. Psychometric properties of the translated versions
using the new scoring were tested. The analyses used in-
cluded: 1) Multitrait analysis (MA) to confirm the con-
struct validity of the proposed model; 2) Cronbach al-
pha’s coefficient to assess internal consistency reliability;
3) Distribution of correlation of scores according to clini-
cal criteria to assess discriminative power of the question-
naire. RESULTS: Results of MA per country data showed
that all items were more correlated to their own scale
than with the other scales, thus providing evidence of
good construct validity. Cronbach’s alpha was found to
be above 0.70 for all dimension in all countries. Scores
were found to be significantly correlated to clinical crite-
ria such as severity of hot flushes and insomnia. Post-
menopausal women reported lower scores than peri and
pre-menopausal women, indicating lower level of QoL
on all scales except menstrual symptoms (P  0.05, Kruskal-
Wallis test). CONCLUSION: The scores obtained from
this research can be used as reference values when using
the WHQ in the UK, US, France, Germany, Italy, Poland.
These reference values will facilitate the interpretation
and understanding of the cross-cultural research using
the WHQ questionnaire.
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OBJECTIVES: An issue in economic evaluation is whose
preferences should be used to determine the value weights
for different health states: values of patients or of the
general public. In the economic evaluation of sildenafil
we were particularly afraid that differences in values be-
tween those two groups would influence the outcomes, as
a consequence of selection and strategic bias, or un-
awareness of the general public of problems related to
erectile dysfunction. We therefore examined the differ-
ences between patients’ values and values of the general
public. METHODS: In a MANOVA repeated measure
analysis we compared the values for the different states
of erectile dysfunction elicited in patients and the general
public. In the analysis we had to deal with opposite bi-
ases. We assumed that strategic or selection bias in pa-
tients would result in lower means, and that differences
in the correlation structure would indicate unawareness
in the general public about the ways in which erectile
dysfunction impairs quality of life. Therefore, when dif-
ferent means occurred, we would still consider the soci-
etal perspective valid as long as there are no significant
differences between patients and the general public with
regard to correlation structure among the values. RE-
SULTS: Patients valued erectile dysfunction lower than
the general public. This result can probably not be attrib-
uted to unawareness of the condition in the general pub-
lic, because the factor structure did not differ. CONCLU-
SIONS: For the appraisal of treatment effects of erectile
dysfunction, societal values should be used. Patients’ val-
ues seem most strongly biased by the fact that they are
currently involved in the trial, resulting in a strategic and
selection bias, which underestimates the current quality
of life.
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OBJECTIVE: Even though Health-related Quality of Life
(HRQL) instruments are increasingly being used, there is
a lack of standardization of administration, interpreta-
tion, and understanding of cross-cultural issues. The ob-
jective of the International Health-related Quality of Life
Outcomes Database (IQOD) program is to further the
methodology of assessing conceptual equivalence of trans-
lated versions and apply this methodology to major
HRQL questionnaires, such as the WHQ. METHODS:
Hypothesized structure of the questionnaire as defined by
its developer was first examined using principal compo-
nent analysis (PCA) and multitrait analysis (MA). These
analyses were performed on the original language version
to test the hypothesized model. The model was then ap-
plied to each language version to evaluate any potential
differences and to provide validation evidence of their
psychometric properties. Data was collected from 4 stud-
ies (observational studies and clinical trials) in the UK,
US, France, Germany, Italy, and Poland. The population
consisted of 9023 peri, pre or post-menopausal women.
RESULTS: The results of PCA and MA on country data
showed that the hypothesized item grouping was not re-
spected. In order to achieve conceptually equivalent trans-
lated versions, a new scoring was developed in collabora-
tion with the developer. This new scoring was applied to
the UK data using Confirmatory Factorial Analysis and
showed that the model was correct (N  811, Chi2 
618.6, normed fit index (NFI)  0.89, goodness of fit in-
dex (GFI)  0.94). The same model was applied to the
pooled sample and fit well (N  6047, Chi2  5715.6,
NFI  0.88, GFI  0.90). Calculation of Cronbach’s al-
pha (	0.70 for all countries) and evaluation of item con-
vergent and divergent criteria showed good internal con-
sistency and construct validity of the translated versions.
CONCLUSION: The methodology used in this program
can be applied to other questionnaires in evaluating
cross-cultural equivalence and thus facilitating interpre-
tation of multi-national studies.
